These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26848303)

  • 1. High Water Intake and Progression of Chronic Kidney Diseases.
    Choi HY; Park HC; Ha SK
    Electrolyte Blood Press; 2015 Dec; 13(2):46-51. PubMed ID: 26848303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Myth of Water and Salt: From Aquaretics to Tenapanor.
    Visconti L; Cernaro V; Calimeri S; Lacquaniti A; De Gregorio F; Ricciardi CA; Lacava V; Santoro D; Buemi M
    J Ren Nutr; 2018 Mar; 28(2):73-82. PubMed ID: 29146141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased water intake decreases progression of polycystic kidney disease in the PCK rat.
    Nagao S; Nishii K; Katsuyama M; Kurahashi H; Marunouchi T; Takahashi H; Wallace DP
    J Am Soc Nephrol; 2006 Aug; 17(8):2220-7. PubMed ID: 16807403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.
    Clark WF; Sontrop JM; Huang SH; Moist L; Bouby N; Bankir L
    Am J Nephrol; 2016; 43(4):281-92. PubMed ID: 27161565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.
    Clark WF; Sontrop JM; Huang SH; Gallo K; Moist L; House AA; Cuerden MS; Weir MA; Bagga A; Brimble S; Burke A; Muirhead N; Pandeya S; Garg AX
    JAMA; 2018 May; 319(18):1870-1879. PubMed ID: 29801012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydration for health hypothesis: a narrative review of supporting evidence.
    Perrier ET; Armstrong LE; Bottin JH; Clark WF; Dolci A; Guelinckx I; Iroz A; Kavouras SA; Lang F; Lieberman HR; Melander O; Morin C; Seksek I; Stookey JD; Tack I; Vanhaecke T; Vecchio M; Péronnet F
    Eur J Nutr; 2021 Apr; 60(3):1167-1180. PubMed ID: 32632658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
    Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK
    BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?
    Kanbay M; Yilmaz S; Dincer N; Ortiz A; Sag AA; Covic A; Sánchez-Lozada LG; Lanaspa MA; Cherney DZI; Johnson RJ; Afsar B
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5406-5420. PubMed ID: 31365096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin beyond water: implications for renal diseases.
    Bolignano D; Zoccali C
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):499-504. PubMed ID: 20689424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention.
    Enhörning S; Melander O
    Ann Nutr Metab; 2018; 72 Suppl 2():21-27. PubMed ID: 29925066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y
    J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is mild dehydration a risk for progression of childhood chronic kidney disease?
    Le Page AK; Johnson EC; Greenberg JH
    Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38632124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
    Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S; Malmberg MES; Rosenbaek JB; Bech JN; Pedersen EB
    BMC Nephrol; 2017 Aug; 18(1):268. PubMed ID: 28810844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of daily sodium intake on vasopressin secretion and drinking in dogs.
    Cowley AW; Skelton MM; Merrill DC; Quillen EW; Switzer SJ
    Am J Physiol; 1983 Dec; 245(6):R860-72. PubMed ID: 6362437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT
    PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydration in rats and mice with polycystic kidney disease.
    Hopp K; Wang X; Ye H; Irazabal MV; Harris PC; Torres VE
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F261-6. PubMed ID: 25503729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.